Shay Capital LLC Athira Pharma, Inc. Transaction History
Shay Capital LLC
- $608 Million
- Q4 2024
A detailed history of Shay Capital LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Shay Capital LLC holds 11,800 shares of ATHA stock, worth $4,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,800Holding current value
$4,602% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATHA
# of Institutions
62Shares Held
18.8MCall Options Held
17.2KPut Options Held
800-
Perceptive Advisors LLC New York, NY5.4MShares$2.11 Million0.11% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.78MShares$1.08 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$607,0930.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$582,1880.05% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$582,1880.87% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $14.7M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...